Company: PSTV
Filing Date: 2025-05-23
Form Type: 8-K
Source: 0001193125-25-125860
Chunk: 2

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-05-23
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item 9.01      Financial Statements and Exhibits.  

(d) Exhibits.

  99.1      Press Release Dated May 23, 2025.                                             
 ──────────────────────────────────────────────────────────────────────────────────────────
   104      Cover Page Interactive Data File (embedded within the Inline XBRL document).  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: May 23, 2025

  PLUS THERAPEUTICS, INC.                                             
  By:                          /s/ Marc H. Hedrick, M. D.             
                               Marc H. Hedrick, M. D.                 
                               President and Chief Executive Officer